← Back
$CRNX All transactions

Crinetics Pharmaceuticals, Inc.

▼ SELL 10b5-1 Plan

$ Value

$180K

Shares

4,000

Price

$45

Filed

Sep 30

Insider

Name

Struthers Richard Scott

Title

President & CEO

CIK

0001746298

Roles

Director Officer

Transaction Details

Transaction Date

2025-09-26

Code

S

Table

Non-Derivative

Ownership

Indirect

Equity Swap

No

Shares After

106,000

Footnotes

The sale reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 30, 2024. | The common stock was sold by the Reporting Person in open market transactions on the transaction date, with a sale price of $45.00 per share.

Filing Info

Accession No.

0001658247-25-000011

Form Type

4

Issuer CIK

0001658247

Struthers Richard Scott's History

Date Ticker Type Value
2026-02-23 CRNX A $0
2026-02-23 CRNX A $0
2025-12-18 CRNX M $152K
2025-12-18 CRNX M $434K
2025-12-18 CRNX M $0
2025-12-18 CRNX M $0
2025-09-26 CRNX $180K
2025-05-14 CRNX G $0
2025-05-14 CRNX G $0

Other Insiders at CRNX (90d)

Insider Bought Sold Last
Schilke Tobin
Chief Financial Officer
$266K 2026-03-03
Okey Stephanie $119K 2026-03-03
Struthers Richard Scott
President & CEO
2026-02-23
Knight Jeff E.
Chief Dev. & Operating Officer
$3.4M 2026-04-08
Knight Jeff E.
Chief Operating Officer
2026-02-23
Betz Stephen F.
Chief Scientific Officer
2026-02-23
Kalofonos Isabel
Chief Commercial Officer
2026-02-23